The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission

Complete Remission ◽

Myeloid Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

The Impact ◽

Minimal Residual ◽

Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-021-03530-9 ◽

2021 ◽

Author(s):

Hong Wang ◽

Xue-Qian Li ◽

Tian-Tian Chu ◽

Shi-Yu Han ◽

Jia-Qian Qi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

Cebpa Mutations ◽

Minimal Residual ◽

Interferon‐α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study

The Oncologist ◽

10.1634/theoncologist.2017-0692 ◽

2018 ◽

Vol 23 (11) ◽

pp. 1349-1357 ◽

Cited By ~ 1

Author(s):

Xiao‐Dong Mo ◽

Yu Wang ◽

Xiao‐Hui Zhang ◽

Lan‐Ping Xu ◽

Chen‐Hua Yan ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Interferon Α ◽

Registry Study ◽

Hematopoietic Stem ◽

Minimal Residual ◽

Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Current Opinion in Hematology ◽

10.1097/moh.0b013e32834bac7d ◽

2011 ◽

Vol 18 (6) ◽

pp. 381-387 ◽

Cited By ~ 9

Author(s):

Alida Dominietto

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

Disease Markers ◽

Before And After ◽

Minimal Residual ◽

Association of Persistent Minimal Residual Disease with Poor Outcomes of Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Chinese Medical Journal ◽

10.4103/0366-6999.246072 ◽

2018 ◽

Vol 131 (23) ◽

pp. 2808 ◽

Cited By ~ 2

Author(s):

Ying-Jun Chang ◽

Jing Liu ◽

Xiao-Su Zhao ◽

Yan-Rong Liu ◽

Lan-Ping Xu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Hematopoietic Stem ◽

Poor Outcomes ◽

Minimal Residual ◽

A Phase 1 Multi-Dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) (NCT04310592)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00199-8 ◽

2021 ◽

Vol 27 (3) ◽

pp. S161-S162

Author(s):

James McCloskey ◽

William B. Donnellan ◽

Solveig Ericson ◽

Erica C Rave ◽

Robert J Hariri

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Phase 1 ◽

Hematopoietic Stem ◽

Secondary Acute Myeloid Leukemia ◽

Dose Study ◽

Minimal Residual ◽

Prognostic Significance of Minimal/Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00165-2 ◽

2021 ◽

Vol 27 (3) ◽

pp. S130-S131

Author(s):

Muhammad Umair Mushtaq ◽

Alexandra M. Harrington ◽

Sibgha Gull Chaudhary ◽

Laura C. Michaelis ◽

Karen-Sue B. Carlson ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Prognostic Significance ◽

Hematopoietic Stem ◽

Refractory Acute Myeloid Leukemia ◽

Measurable Residual Disease ◽

Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome

Current Opinion in Hematology ◽

10.1097/moh.0000000000000464 ◽

2018 ◽

Vol 25 (6) ◽

pp. 425-432 ◽

Cited By ~ 6

Author(s):

Roman M. Shapiro ◽

Dennis Dong Hwan Kim

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Disease Monitoring ◽

Hematopoietic Stem ◽

Minimal Residual Disease Monitoring ◽

Generation Sequencing ◽

Minimal Residual ◽

Impact of Blood Count Recovery-based Complete Remission Before Allogeneic Hematopoietic Stem Cell Transplantation on Survival in Patients With Acute Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2018.12.006 ◽

2019 ◽

Vol 19 (5) ◽

pp. e205-e212

Author(s):

Rafiye Ciftciler ◽

Haluk Demiroglu ◽

Yahya Buyukasık ◽

Salih Aksu ◽

Hakan Goker

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Myeloid Leukemia ◽

Blood Count ◽

Hematopoietic Stem ◽

Acute Myeloid ◽

Count Recovery

Response‐guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML‐01

Pediatric Blood & Cancer ◽

10.1002/pbc.27605 ◽

2019 ◽

Vol 66 (5) ◽

pp. e27605 ◽

Cited By ~ 5

Author(s):

Barbara Moerloose ◽

Ardine Reedijk ◽

Geertruida H Bock ◽

Tim Lammens ◽

Valerie Haas ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Pediatric Acute Myeloid Leukemia ◽

First Complete Remission ◽

WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and Candidates

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.05.033 ◽

2019 ◽

Vol 25 (10) ◽

pp. 1925-1932 ◽

Cited By ~ 11

Author(s):

Byung-Sik Cho ◽

Gi-June Min ◽

Sung-Su Park ◽

Seung-Hwan Shin ◽

Seung-Ah Yahng ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Myeloid Leukemia ◽

Residual Disease ◽

Optimal Time ◽

Hematopoietic Stem ◽

Time Points ◽

Measurable Residual Disease ◽